COVID-19 Impact on Global Chronic Myeloid Leukemia (CML) Treatment Market Size, Status and Forecast 2020-2026

COVID-19 Impact on Global Chronic Myeloid Leukemia (CML) Treatment Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Chronic Myeloid Leukemia (CML) Treatment Revenue
1.4 Market Analysis by Type
1.4.1 Global Chronic Myeloid Leukemia (CML) Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Targeted Therapy
1.4.3 Chemotherapy
1.4.4 Radiation Therapy
1.4.5 Splenectomy
1.4.6 Stem Cell Transplant
1.5 Market by Application
1.5.1 Global Chronic Myeloid Leukemia (CML) Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinic
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Chronic Myeloid Leukemia (CML) Treatment Industry Impact
1.6.1 How the Covid-19 is Affecting the Chronic Myeloid Leukemia (CML) Treatment Industry
1.6.1.1 Chronic Myeloid Leukemia (CML) Treatment Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Chronic Myeloid Leukemia (CML) Treatment Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Chronic Myeloid Leukemia (CML) Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Chronic Myeloid Leukemia (CML) Treatment Market Perspective (2015-2026)
2.2 Chronic Myeloid Leukemia (CML) Treatment Growth Trends by Regions
2.2.1 Chronic Myeloid Leukemia (CML) Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Chronic Myeloid Leukemia (CML) Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Chronic Myeloid Leukemia (CML) Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Chronic Myeloid Leukemia (CML) Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Chronic Myeloid Leukemia (CML) Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Chronic Myeloid Leukemia (CML) Treatment Players by Market Size
3.1.1 Global Top Chronic Myeloid Leukemia (CML) Treatment Players by Revenue (2015-2020)
3.1.2 Global Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Chronic Myeloid Leukemia (CML) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Chronic Myeloid Leukemia (CML) Treatment Market Concentration Ratio
3.2.1 Global Chronic Myeloid Leukemia (CML) Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Chronic Myeloid Leukemia (CML) Treatment Revenue in 2019
3.3 Chronic Myeloid Leukemia (CML) Treatment Key Players Head office and Area Served
3.4 Key Players Chronic Myeloid Leukemia (CML) Treatment Product Solution and Service
3.5 Date of Enter into Chronic Myeloid Leukemia (CML) Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Chronic Myeloid Leukemia (CML) Treatment Historic Market Size by Type (2015-2020)
4.2 Global Chronic Myeloid Leukemia (CML) Treatment Forecasted Market Size by Type (2021-2026)
5 Chronic Myeloid Leukemia (CML) Treatment Breakdown Data by Application (2015-2026)
5.1 Global Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020)
5.2 Global Chronic Myeloid Leukemia (CML) Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Chronic Myeloid Leukemia (CML) Treatment Market Size (2015-2020)
6.2 Chronic Myeloid Leukemia (CML) Treatment Key Players in North America (2019-2020)
6.3 North America Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020)
6.4 North America Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Chronic Myeloid Leukemia (CML) Treatment Market Size (2015-2020)
7.2 Chronic Myeloid Leukemia (CML) Treatment Key Players in Europe (2019-2020)
7.3 Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020)
7.4 Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020)
8 China
8.1 China Chronic Myeloid Leukemia (CML) Treatment Market Size (2015-2020)
8.2 Chronic Myeloid Leukemia (CML) Treatment Key Players in China (2019-2020)
8.3 China Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020)
8.4 China Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Chronic Myeloid Leukemia (CML) Treatment Market Size (2015-2020)
9.2 Chronic Myeloid Leukemia (CML) Treatment Key Players in Japan (2019-2020)
9.3 Japan Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020)
9.4 Japan Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Chronic Myeloid Leukemia (CML) Treatment Market Size (2015-2020)
10.2 Chronic Myeloid Leukemia (CML) Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020)
11 India
11.1 India Chronic Myeloid Leukemia (CML) Treatment Market Size (2015-2020)
11.2 Chronic Myeloid Leukemia (CML) Treatment Key Players in India (2019-2020)
11.3 India Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020)
11.4 India Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Chronic Myeloid Leukemia (CML) Treatment Market Size (2015-2020)
12.2 Chronic Myeloid Leukemia (CML) Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020)
12.4 Central & South America Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Novartis AG
13.1.1 Novartis AG Company Details
13.1.2 Novartis AG Business Overview and Its Total Revenue
13.1.3 Novartis AG Chronic Myeloid Leukemia (CML) Treatment Introduction
13.1.4 Novartis AG Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020))
13.1.5 Novartis AG Recent Development
13.2 Bristol-Myers Squibb
13.2.1 Bristol-Myers Squibb Company Details
13.2.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
13.2.3 Bristol-Myers Squibb Chronic Myeloid Leukemia (CML) Treatment Introduction
13.2.4 Bristol-Myers Squibb Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
13.2.5 Bristol-Myers Squibb Recent Development
13.3 Teva Pharmaceuticals Industries Ltd.
13.3.1 Teva Pharmaceuticals Industries Ltd. Company Details
13.3.2 Teva Pharmaceuticals Industries Ltd. Business Overview and Its Total Revenue
13.3.3 Teva Pharmaceuticals Industries Ltd. Chronic Myeloid Leukemia (CML) Treatment Introduction
13.3.4 Teva Pharmaceuticals Industries Ltd. Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
13.3.5 Teva Pharmaceuticals Industries Ltd. Recent Development
13.4 ARIAD Pharmaceuticals, Inc.
13.4.1 ARIAD Pharmaceuticals, Inc. Company Details
13.4.2 ARIAD Pharmaceuticals, Inc. Business Overview and Its Total Revenue
13.4.3 ARIAD Pharmaceuticals, Inc. Chronic Myeloid Leukemia (CML) Treatment Introduction
13.4.4 ARIAD Pharmaceuticals, Inc. Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
13.4.5 ARIAD Pharmaceuticals, Inc. Recent Development
13.5 Pfizer, Inc.
13.5.1 Pfizer, Inc. Company Details
13.5.2 Pfizer, Inc. Business Overview and Its Total Revenue
13.5.3 Pfizer, Inc. Chronic Myeloid Leukemia (CML) Treatment Introduction
13.5.4 Pfizer, Inc. Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
13.5.5 Pfizer, Inc. Recent Development
13.6 Hospira, Inc.
13.6.1 Hospira, Inc. Company Details
13.6.2 Hospira, Inc. Business Overview and Its Total Revenue
13.6.3 Hospira, Inc. Chronic Myeloid Leukemia (CML) Treatment Introduction
13.6.4 Hospira, Inc. Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
13.6.5 Hospira, Inc. Recent Development
13.7 Prism Pharmaceuticals
13.7.1 Prism Pharmaceuticals Company Details
13.7.2 Prism Pharmaceuticals Business Overview and Its Total Revenue
13.7.3 Prism Pharmaceuticals Chronic Myeloid Leukemia (CML) Treatment Introduction
13.7.4 Prism Pharmaceuticals Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
13.7.5 Prism Pharmaceuticals Recent Development
13.8 Incyte Corporation
13.8.1 Incyte Corporation Company Details
13.8.2 Incyte Corporation Business Overview and Its Total Revenue
13.8.3 Incyte Corporation Chronic Myeloid Leukemia (CML) Treatment Introduction
13.8.4 Incyte Corporation Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
13.8.5 Incyte Corporation Recent Development
13.9 Bio-Path Holdings
13.9.1 Bio-Path Holdings Company Details
13.9.2 Bio-Path Holdings Business Overview and Its Total Revenue
13.9.3 Bio-Path Holdings Chronic Myeloid Leukemia (CML) Treatment Introduction
13.9.4 Bio-Path Holdings Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
13.9.5 Bio-Path Holdings Recent Development
13.10 Stragen Pharma SA
13.10.1 Stragen Pharma SA Company Details
13.10.2 Stragen Pharma SA Business Overview and Its Total Revenue
13.10.3 Stragen Pharma SA Chronic Myeloid Leukemia (CML) Treatment Introduction
13.10.4 Stragen Pharma SA Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
13.10.5 Stragen Pharma SA Recent Development
13.11 Otsuka Pharmaceutical Co., Ltd.
10.11.1 Otsuka Pharmaceutical Co., Ltd. Company Details
10.11.2 Otsuka Pharmaceutical Co., Ltd. Business Overview and Its Total Revenue
10.11.3 Otsuka Pharmaceutical Co., Ltd. Chronic Myeloid Leukemia (CML) Treatment Introduction
10.11.4 Otsuka Pharmaceutical Co., Ltd. Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
10.11.5 Otsuka Pharmaceutical Co., Ltd. Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Chronic Myeloid Leukemia (CML) Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Chronic Myeloid Leukemia (CML) Treatment Revenue
Table 3. Ranking of Global Top Chronic Myeloid Leukemia (CML) Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Chronic Myeloid Leukemia (CML) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Targeted Therapy
Table 6. Key Players of Chemotherapy
Table 7. Key Players of Radiation Therapy
Table 8. Key Players of Splenectomy
Table 9. Key Players of Stem Cell Transplant
Table 10. COVID-19 Impact Global Market: (Four Chronic Myeloid Leukemia (CML) Treatment Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Chronic Myeloid Leukemia (CML) Treatment Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Chronic Myeloid Leukemia (CML) Treatment Players to Combat Covid-19 Impact
Table 15. Global Chronic Myeloid Leukemia (CML) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Chronic Myeloid Leukemia (CML) Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Chronic Myeloid Leukemia (CML) Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Chronic Myeloid Leukemia (CML) Treatment Market Share by Regions (2015-2020)
Table 19. Global Chronic Myeloid Leukemia (CML) Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Chronic Myeloid Leukemia (CML) Treatment Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Chronic Myeloid Leukemia (CML) Treatment Market Growth Strategy
Table 25. Main Points Interviewed from Key Chronic Myeloid Leukemia (CML) Treatment Players
Table 26. Global Chronic Myeloid Leukemia (CML) Treatment Revenue by Players (2015-2020) (Million US$)
Table 27. Global Chronic Myeloid Leukemia (CML) Treatment Market Share by Players (2015-2020)
Table 28. Global Top Chronic Myeloid Leukemia (CML) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Myeloid Leukemia (CML) Treatment as of 2019)
Table 29. Global Chronic Myeloid Leukemia (CML) Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Chronic Myeloid Leukemia (CML) Treatment Product Solution and Service
Table 32. Date of Enter into Chronic Myeloid Leukemia (CML) Treatment Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. Global Chronic Myeloid Leukemia (CML) Treatment Market Size Share by Type (2015-2020)
Table 36. Global Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share by Type (2021-2026)
Table 37. Global Chronic Myeloid Leukemia (CML) Treatment Market Size Share by Application (2015-2020)
Table 38. Global Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. Global Chronic Myeloid Leukemia (CML) Treatment Market Size Share by Application (2021-2026)
Table 40. North America Key Players Chronic Myeloid Leukemia (CML) Treatment Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Chronic Myeloid Leukemia (CML) Treatment Market Share (2019-2020)
Table 42. North America Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. North America Chronic Myeloid Leukemia (CML) Treatment Market Share by Type (2015-2020)
Table 44. North America Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. North America Chronic Myeloid Leukemia (CML) Treatment Market Share by Application (2015-2020)
Table 46. Europe Key Players Chronic Myeloid Leukemia (CML) Treatment Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Chronic Myeloid Leukemia (CML) Treatment Market Share (2019-2020)
Table 48. Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Chronic Myeloid Leukemia (CML) Treatment Market Share by Type (2015-2020)
Table 50. Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Chronic Myeloid Leukemia (CML) Treatment Market Share by Application (2015-2020)
Table 52. China Key Players Chronic Myeloid Leukemia (CML) Treatment Revenue (2019-2020) (Million US$)
Table 53. China Key Players Chronic Myeloid Leukemia (CML) Treatment Market Share (2019-2020)
Table 54. China Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. China Chronic Myeloid Leukemia (CML) Treatment Market Share by Type (2015-2020)
Table 56. China Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. China Chronic Myeloid Leukemia (CML) Treatment Market Share by Application (2015-2020)
Table 58. Japan Key Players Chronic Myeloid Leukemia (CML) Treatment Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Chronic Myeloid Leukemia (CML) Treatment Market Share (2019-2020)
Table 60. Japan Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Chronic Myeloid Leukemia (CML) Treatment Market Share by Type (2015-2020)
Table 62. Japan Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Chronic Myeloid Leukemia (CML) Treatment Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Chronic Myeloid Leukemia (CML) Treatment Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Chronic Myeloid Leukemia (CML) Treatment Market Share (2019-2020)
Table 66. Southeast Asia Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Chronic Myeloid Leukemia (CML) Treatment Market Share by Type (2015-2020)
Table 68. Southeast Asia Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Chronic Myeloid Leukemia (CML) Treatment Market Share by Application (2015-2020)
Table 70. India Key Players Chronic Myeloid Leukemia (CML) Treatment Revenue (2019-2020) (Million US$)
Table 71. India Key Players Chronic Myeloid Leukemia (CML) Treatment Market Share (2019-2020)
Table 72. India Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. India Chronic Myeloid Leukemia (CML) Treatment Market Share by Type (2015-2020)
Table 74. India Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. India Chronic Myeloid Leukemia (CML) Treatment Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Chronic Myeloid Leukemia (CML) Treatment Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Chronic Myeloid Leukemia (CML) Treatment Market Share (2019-2020)
Table 78. Central & South America Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Chronic Myeloid Leukemia (CML) Treatment Market Share by Type (2015-2020)
Table 80. Central & South America Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Chronic Myeloid Leukemia (CML) Treatment Market Share by Application (2015-2020)
Table 82. Novartis AG Company Details
Table 83. Novartis AG Business Overview
Table 84. Novartis AG Product
Table 85. Novartis AG Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020) (Million US$)
Table 86. Novartis AG Recent Development
Table 87. Bristol-Myers Squibb Company Details
Table 88. Bristol-Myers Squibb Business Overview
Table 89. Bristol-Myers Squibb Product
Table 90. Bristol-Myers Squibb Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020) (Million US$)
Table 91. Bristol-Myers Squibb Recent Development
Table 92. Teva Pharmaceuticals Industries Ltd. Company Details
Table 93. Teva Pharmaceuticals Industries Ltd. Business Overview
Table 94. Teva Pharmaceuticals Industries Ltd. Product
Table 95. Teva Pharmaceuticals Industries Ltd. Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020) (Million US$)
Table 96. Teva Pharmaceuticals Industries Ltd. Recent Development
Table 97. ARIAD Pharmaceuticals, Inc. Company Details
Table 98. ARIAD Pharmaceuticals, Inc. Business Overview
Table 99. ARIAD Pharmaceuticals, Inc. Product
Table 100. ARIAD Pharmaceuticals, Inc. Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020) (Million US$)
Table 101. ARIAD Pharmaceuticals, Inc. Recent Development
Table 102. Pfizer, Inc. Company Details
Table 103. Pfizer, Inc. Business Overview
Table 104. Pfizer, Inc. Product
Table 105. Pfizer, Inc. Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020) (Million US$)
Table 106. Pfizer, Inc. Recent Development
Table 107. Hospira, Inc. Company Details
Table 108. Hospira, Inc. Business Overview
Table 109. Hospira, Inc. Product
Table 110. Hospira, Inc. Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020) (Million US$)
Table 111. Hospira, Inc. Recent Development
Table 112. Prism Pharmaceuticals Company Details
Table 113. Prism Pharmaceuticals Business Overview
Table 114. Prism Pharmaceuticals Product
Table 115. Prism Pharmaceuticals Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020) (Million US$)
Table 116. Prism Pharmaceuticals Recent Development
Table 117. Incyte Corporation Business Overview
Table 118. Incyte Corporation Product
Table 119. Incyte Corporation Company Details
Table 120. Incyte Corporation Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020) (Million US$)
Table 121. Incyte Corporation Recent Development
Table 122. Bio-Path Holdings Company Details
Table 123. Bio-Path Holdings Business Overview
Table 124. Bio-Path Holdings Product
Table 125. Bio-Path Holdings Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020) (Million US$)
Table 126. Bio-Path Holdings Recent Development
Table 127. Stragen Pharma SA Company Details
Table 128. Stragen Pharma SA Business Overview
Table 129. Stragen Pharma SA Product
Table 130. Stragen Pharma SA Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020) (Million US$)
Table 131. Stragen Pharma SA Recent Development
Table 132. Otsuka Pharmaceutical Co., Ltd. Company Details
Table 133. Otsuka Pharmaceutical Co., Ltd. Business Overview
Table 134. Otsuka Pharmaceutical Co., Ltd. Product
Table 135. Otsuka Pharmaceutical Co., Ltd. Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020) (Million US$)
Table 136. Otsuka Pharmaceutical Co., Ltd. Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Myeloid Leukemia (CML) Treatment Market Share by Type: 2020 VS 2026
Figure 2. Targeted Therapy Features
Figure 3. Chemotherapy Features
Figure 4. Radiation Therapy Features
Figure 5. Splenectomy Features
Figure 6. Stem Cell Transplant Features
Figure 7. Global Chronic Myeloid Leukemia (CML) Treatment Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Chronic Myeloid Leukemia (CML) Treatment Report Years Considered
Figure 12. Global Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Chronic Myeloid Leukemia (CML) Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Chronic Myeloid Leukemia (CML) Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Chronic Myeloid Leukemia (CML) Treatment Market Share by Players in 2019
Figure 17. Global Top Chronic Myeloid Leukemia (CML) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Myeloid Leukemia (CML) Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Chronic Myeloid Leukemia (CML) Treatment Revenue in 2019
Figure 19. North America Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Novartis AG Revenue Growth Rate in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
Figure 28. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Bristol-Myers Squibb Revenue Growth Rate in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
Figure 30. Teva Pharmaceuticals Industries Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Teva Pharmaceuticals Industries Ltd. Revenue Growth Rate in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
Figure 32. ARIAD Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. ARIAD Pharmaceuticals, Inc. Revenue Growth Rate in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
Figure 34. Pfizer, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Pfizer, Inc. Revenue Growth Rate in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
Figure 36. Hospira, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Hospira, Inc. Revenue Growth Rate in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
Figure 38. Prism Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Prism Pharmaceuticals Revenue Growth Rate in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
Figure 40. Incyte Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Incyte Corporation Revenue Growth Rate in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
Figure 42. Bio-Path Holdings Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Bio-Path Holdings Revenue Growth Rate in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
Figure 44. Stragen Pharma SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Stragen Pharma SA Revenue Growth Rate in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
Figure 46. Otsuka Pharmaceutical Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Otsuka Pharmaceutical Co., Ltd. Revenue Growth Rate in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs